Interim Results

28th Sep 2005 07:03

Evolutec Group PLC28 September 2005 For immediate release 28 September 2005 EVOLUTEC GROUP PLC ("Evolutec" or the "Company") INTERIM FINANCIAL RESULTS Evolutec Group plc (AIM: EVC), a biopharmaceutical company developing smallprotein therapeutics for allergy, inflammation and auto-immune diseases, ispleased to announce its interim results for the 6 month period to 30 June 2005. Highlights to date • rEV131 - Positive Phase II result announced ahead of schedule in allergic rhinitis (hay fever)• rEV131 - Significantly reduced (p

---

Related Shares:

Nanoco